Mirum Pharmaceuticals (MIRM) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.63
-0.5
-0.37
-0.24

Details

Expected EPS
-0.449434
Actual EPS
-0.3
Surprise EPS
0.15
Surprise Percent
+33.25%

Description

Mirum Pharmaceuticals (MIRM) has reported earnings of -0.3 per share for Q4 2024.

0 Comments

Share your thoughts